Introduction
Radioimmunoassay represented a major methodological advance in endocrinology. However, the immunoheterogeneity of some hormones resulted in varying diagnostic sensitivities and specificities and limited their clinical utility. Parathyroid hormone (PTH) was one such hormone, being rapidly metabolized in liver and kidney [1] to yield aminoterminal (amino acid 1-34) and carboxyl terminal (aa 35-85) and other polypeptides. Armitage [2] in a recent review of parathyroid assay performance listed reported studies showing that C-terminal and mid-molecular assays provided clearer discrimination than N-terminal assays between normal and abnormal parathyroid function. The N-terminal assays reflect better acute changes in parathyroid function [2 and 3] .
In this report two commercial assays one with C-terminal and whole hormone specificity (Dac cell) and one with recognition for the mid-molecular region of PTH (Omega assay) are compared, and their clinical utility are discussed with particular reference to the prevalence of primary hyperparathyroidism in various population groups. Material figure 1 ). When a small number of serum samples subjected to one freeze/thaw cycle (N 6) or two freeze/thaw cycles (N 4) were compared to the basal value, no marked change in PTH occurred (see figure 1 ). 
Results
The precision, both within and between batch, for both assays is shown in table 2. Between-batch precision was similar for both assays giving CV values of 10.4% and 10"6% for the C-terminal assay and 9"4% and 10"2% for the mid-molecule PTH assay. Recovery of added PTH from serum gave a mean value of92"4% (range 90"9-93"3) for the C-terminal assay, compared to a mean recovery of 92"3% (80-103"7%) for the mid molecular PTH method (N 6). A series of replicates of the zero standard (N 20) were assayed and two standard deviations from the mean PTH concentration was 0"13 g/1 and 0"27 tg/1 of serum for the C-terminal and mid-molecular assays respectively. This was the calculated minimum detectable amount of PTH in serum.
A reference range was established by assay of PTH in the serum of apparently healthy subjects-age group 18-62 years-N 41 for the C-terminal assay and N 26 for the mid-molecular assay. Using the C-terminal assay, serum PTH was detectable in 19 of 41 subjects and ranged from 0" 13 g/1 to 0"40 tg/1. Log transformation of this data yielded a 95% range of 0"08-0"34 g/1. Serum PTH was detectable in all but two of the 26 control subjects. When the mid-molecular PTH assay was performed, the mean PTH value was 0"69 ng/ml and the 95% (+ 2SD) range was 0"19-1.19 tg/1. Log transformation of this data yielded a 95% range of 0"31-1"36 g/1.
Primary hyperparathyroidism (PHPT)
Serum PTH (C-terminal) in 20 patients with surgically proven PHPT was higher than control values in all but three cases (see figure 2) . The suspected PHPT group were hypercalcaemic patients in whom the diagnosis of Table 2 . Precision of PTH measurements using the C-terminal (Dac Cell) and mid-molecule (Omega) assays. 
Idiopathic hypercalciuria (IH)
Serum PTH was measured in the serum of 10 normocalcaemic stone-forming subjects. The C-terminal assay failed to detect PTH in six of 10 patients and four fell within the reference range (see figure 2) . PTH values obtained with the mid-molecule assay were not significantly different from control values and serum PTH was detectable in all 10 patients (see figure 3 ). Serum PTH values in all patients assayed by both methods yielded a correlation coefficient r 0"844 (N 74). The correlation between PTH values by both methods in the surgically proven PHPT group alone was 0"806 (N 20), and when the proven PHPT and hypoparathyroid groups were combined (N 31) the correlation coefficient was 0"841.
Discussion
In the past, PTH assays included antisera which recognized either the N-terminal or C-terminal fragments of the parathyroid hormone molecule. PTH assays using an antiserum with mid-molecule specificity are now being more widely used [6] [7] [8] [9] [10] .
This comparison of C-terminal and mid-molecule PTH assays shows that both commercial assays provide moderately precise methods of determining PTH in serum and both provide results within 24 h. This previously reported in-house assays required four to six days for completion.
Studies reported here and in a previous publication [5] indicate the stability of both mid-molecule and C-terminal fragments of PTH in serum.
The mid-molecule PTH assay was marginally better in the diagnosis of primary hyperparathyroidism and in combination with serum calcium gave better separation between PHPT and hypercalcaemic patients with malignant disease. Nisbet [10] 
